To explore whether silencing of LRP5 could enhance the sensitivity of CRC cells to the treatment of cisplatin, proliferation indices of cells exposed to cisplatin were real‐time monitored via RTCA system. This evidence concerns the gene LRP5 and colorectal carcinoma.